Russell Frank Company’s Novo Nordisk NVO Stock Holding History

Russell Frank Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.63M	Sell	60,298 -161,026	-73%	-$4.31M	﹤0.01%	1954
2015 Q4	$6.5M	Buy	221,324 +107,700	+95%	+$2.98M	0.01%	1130
2015 Q3	$3.08M	Buy	113,624 +40,348	+55%	+$1.14M	0.01%	1589
2015 Q2	$2.01M	Buy	73,276 +16,142	+28%	+$454K	﹤0.01%	1967
2015 Q1	$1.52M	Sell	57,134 -68,452	-55%	-$1.58M	﹤0.01%	1932
2014 Q4	$2.68M	Sell	125,586 -15,856	-11%	-$354K	﹤0.01%	1620
2014 Q3	$3.37M	Buy	141,442 +76,696	+118%	+$1.76M	0.01%	1506
2014 Q2	$1.5M	Buy	64,746 +22,896	+55%	+$506K	﹤0.01%	1883
2014 Q1	$955K	Sell	41,850 -1,633,560	-98%	-$34.8M	﹤0.01%	2108
2013 Q4	$6.56M	Sell	1,675,410 -217,010	-11%	-$3.78M	0.01%	1074
2013 Q3	$32M	Sell	1,892,420 -559,600	-23%	-$9.41M	0.06%	385
2013 Q2	$38M	Buy	+2,452,020	New	+$40.8M	0.07%	327

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Russell Frank Company's NVO Position: Q1 2016 in Review

Russell Frank Company reduced its Novo Nordisk (NVO) stake by 73% in Q1 2016, selling an estimated $4.31M and leaving 60,298 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Russell Frank Company first reported a position in NVO in Q2 2013 and has held it in 12 quarters since. The position peaked at $38M in Q2 2013. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Russell Frank Company held 60,298 shares of Novo Nordisk worth $1.63M as of Q1 2016.
Russell Frank Company sold 161,026 Novo Nordisk shares in Q1 2016, an estimated $4.31M.
Novo Nordisk made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1954 holding.
Russell Frank Company first reported a position in Novo Nordisk in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Novo Nordisk position peaked at $38M in Q2 2013.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.